{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,3,27]],"date-time":"2025-03-27T15:22:47Z","timestamp":1743088967762,"version":"3.40.3"},"publisher-location":"New York, NY","reference-count":44,"publisher":"Springer US","isbn-type":[{"type":"print","value":"9781071607947"},{"type":"electronic","value":"9781071607954"}],"license":[{"start":{"date-parts":[[2020,9,22]],"date-time":"2020-09-22T00:00:00Z","timestamp":1600732800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,9,22]],"date-time":"2020-09-22T00:00:00Z","timestamp":1600732800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021]]},"DOI":"10.1007\/978-1-0716-0795-4_6","type":"book-chapter","created":{"date-parts":[[2020,9,21]],"date-time":"2020-09-21T16:11:58Z","timestamp":1600704718000},"page":"63-81","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Alphavirus-Based Antigen Preparation"],"prefix":"10.1007","author":[{"given":"Kenneth","family":"Lundstrom","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,9,22]]},"reference":[{"key":"6_CR1","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1128\/mr.58.3.491-562.1994","volume":"58","author":"J Strauss","year":"1994","unstructured":"Strauss J, Strauss E (1994) The alphaviruses; gene expression, replication and evolution. Microbiol Rev 58:491\u2013562","journal-title":"Microbiol Rev"},{"key":"6_CR2","doi-asserted-by":"publisher","first-page":"1356","DOI":"10.1038\/nbt1291-1356","volume":"9","author":"P Liljestrom","year":"1991","unstructured":"Liljestrom P, Garoff H (1991) A new generation of animal cell expression vectors based on the Semliki Forest virus replicon. Bio\/Technology 9:1356\u20131361","journal-title":"Bio\/Technology"},{"key":"6_CR3","doi-asserted-by":"publisher","first-page":"1188","DOI":"10.1126\/science.2922607","volume":"243","author":"C Xiong","year":"1989","unstructured":"Xiong C, Levis R, Shen P, Schlesinger S, Rice CM, Huang HV (1989) Sindbis virus: an efficient, broad host range vector for gene expression in animal cells. Science 243:1188\u20131191","journal-title":"Science"},{"key":"6_CR4","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/0042-6822(89)90526-6","volume":"171","author":"NL Davies","year":"1989","unstructured":"Davies NL, Brown KW, Johnston RE (1989) In vitro synthesis of infectious Venezuelan equine encephalitis virus RNA from a cDNA clone: analysis of a viable deletion mutant. Virologie 171:189\u2013204","journal-title":"Virologie"},{"key":"6_CR5","doi-asserted-by":"publisher","first-page":"2392","DOI":"10.3390\/v6062392","volume":"6","author":"K Lundstrom","year":"2014","unstructured":"Lundstrom K (2014) Alphavirus-based vaccines. Viruses 6:2392\u20132415","journal-title":"Viruses"},{"key":"6_CR6","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1006\/viro.2000.0635","volume":"278","author":"S Schultz-Cherry","year":"2000","unstructured":"Schultz-Cherry S, Dybing JK, Davis NL, Williamson C, Suarez DL, Johnston R et al (2000) Influenza virus (A\/HK\/156\/97) hemagglutinin expressed by an alphavirus replicon system protects against lethal infection with Hong Kong-origin H5N1 viruses. Virology 278:55\u201359","journal-title":"Virology"},{"key":"6_CR7","doi-asserted-by":"publisher","first-page":"1395","DOI":"10.1086\/319857","volume":"183","author":"MN Fleeton","year":"2001","unstructured":"Fleeton MN, Chen M, Berglund P, Rhodes G, Parker SE, Murphy M et al (2001) Self-replicative RNA vaccines elicit protection against influenza A virus, respiratory syncytial virus, and a tickborne encephalitis virus. J Infect Dis 183:1395\u20131398","journal-title":"J Infect Dis"},{"key":"6_CR8","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1016\/j.vaccine.2017.12.046","volume":"36","author":"M Wang","year":"2018","unstructured":"Wang M, Jokinen J, Tretyakova I, Pushko P, Luikashevich IS (2018) Alphavirus vector-based replicon particles expressing multivalent cross-protective Lassa virus glycoproteins. Vaccine 36:683\u2013690","journal-title":"Vaccine"},{"key":"6_CR9","doi-asserted-by":"publisher","first-page":"2660","DOI":"10.1128\/JVI.75.6.2660-2664.2001","volume":"75","author":"JA Wilson","year":"2001","unstructured":"Wilson JA, Hart MK (2001) Protection from Ebola virus mediated by cytotoxic T-lymphocytes specific for the viral nucleoprotein. J Virol 75:2660\u20132664","journal-title":"J Virol"},{"key":"6_CR10","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/S0264-410X(00)00113-4","volume":"19","author":"P Pushko","year":"2000","unstructured":"Pushko P, Bray M, Ludwig GV, Parker M, Schmaljohn A, Sanchez A et al (2000) Recombinant RNA replicons derived from attenuated Venezuelan equine encephalitis virus protect guinea pigs and mice from Ebola hemorrhagic fever virus. Vaccine 19:142\u2013153","journal-title":"Vaccine"},{"key":"6_CR11","doi-asserted-by":"publisher","first-page":"4952","DOI":"10.1128\/JVI.03361-12","volume":"87","author":"AS Herbert","year":"2013","unstructured":"Herbert AS, Kuehne AI, Barth JF, Ortiz RA, Nichols DK, Zak SE et al (2013) Venezuelan equine encephalitis virus replicon particle vaccine protects nonhuman primates from intramuscular and aerosol challenge with Ebolavirus. J Virol 87:4952\u20134964","journal-title":"J Virol"},{"key":"6_CR12","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1016\/j.ymthe.2017.11.017","volume":"26","author":"AB Vogel","year":"2018","unstructured":"Vogel AB, Lambert L, Kinnear E, Busse D, Erbar S, Reuter KC et al (2018) Self-amplifying RNA vaccines give equivalent protection against influenza to mRNA vaccines but at much lower doses. Mol Ther 26:446\u2013455","journal-title":"Mol Ther"},{"key":"6_CR13","doi-asserted-by":"publisher","first-page":"950","DOI":"10.1128\/JVI.72.2.950-958.1998","volume":"72","author":"MJ Hariharan","year":"1998","unstructured":"Hariharan MJ, Driver DA, Townsend K, Brumm D, Polo JM, Belli BA et al (1998) DNA immunization against herpes simplex virus: enhanced efficacy using a Sindbis virus-based vector. J Virol 72:950\u2013958","journal-title":"J Virol"},{"key":"6_CR14","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1128\/IAI.71.1.575-579.2003","volume":"71","author":"JR Kirman","year":"2003","unstructured":"Kirman JR, Turon T, Su H, Li A, Kraus C, Polo JM et al (2003) Enhanced immunogenicity to Mycobacterium tuberculosis by vaccination with an alphavirus plasmid replicon expressing antigen 85A. Infect Immun 71:575\u2013579","journal-title":"Infect Immun"},{"key":"6_CR15","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/S0147-9571(99)00014-4","volume":"22","author":"JR Reddy","year":"1999","unstructured":"Reddy JR, Kwang J, Varthakavi V, Lechtenberg KF, Minocha HC (1999) Semliki Forest virus vector carrying the bovine viral diarrhea virus NS3 (p80) cDNA induced immune responses in mice and expressed BVDV protein in mammalian cells. Comp Immunol Microbiol Infect Dis 22:231\u2013246","journal-title":"Comp Immunol Microbiol Infect Dis"},{"key":"6_CR16","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0117042","volume":"10","author":"ML Knudsen","year":"2015","unstructured":"Knudsen ML, Ljungberg K, Tatoud R, Weber J, Esteban M, Liljestrom P (2015) Alphavirus replicon DNA expressing HIV antigens is an excellent prime for boosting with recombinant Ankara (MVA) or with HIV gp140 protein antigen. PLoS One 10:e0117042","journal-title":"PLoS One"},{"key":"6_CR17","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1111\/j.1365-2990.2010.01110.x","volume":"36","author":"FP Roche","year":"2010","unstructured":"Roche FP, Sheahan BJ, O\u2019Mara SM, Atkins GJ (2010) Semliki Forest virus-mediated gene therapy of the RG2 rat glioma. Neuropathol Appl Neurobiol 36:648\u2013660","journal-title":"Neuropathol Appl Neurobiol"},{"key":"6_CR18","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1128\/JVI.01940-12","volume":"87","author":"E Ylosmaki","year":"2013","unstructured":"Ylosmaki E, Martikainen M, Hinkkanen A, Saksela K (2013) Attenuation of Semliki Forest virus neurovirulence by microRNA-mediated detargeting. J Virol 87:335\u2013344","journal-title":"J Virol"},{"key":"6_CR19","doi-asserted-by":"publisher","first-page":"E4504","DOI":"10.1073\/pnas.1408759111","volume":"111","author":"Y Lin","year":"2014","unstructured":"Lin Y, Zhang H, Liang J, Li K, Zhu W, Fu L, Wang F, Zheng X, Shi H, Wu S et al (2014) Identification and characterization of alphavirus M1 as a selective oncolytic virus targeting ZAP-defective human cancers. Proc Natl Acad Sci U S A 111:E4504\u2013E4512","journal-title":"Proc Natl Acad Sci U S A"},{"key":"6_CR20","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1038\/10548","volume":"5","author":"H Ying","year":"1999","unstructured":"Ying H, Zaks TZ, Wang R-F, Irvine KR, Kammula US, Marincola FM et al (1999) Cancer therapy using a self-replicating RNA vaccine. Nat Med 5:823\u2013827","journal-title":"Nat Med"},{"key":"6_CR21","doi-asserted-by":"publisher","DOI":"10.1080\/2162402X.2018.1487913","volume":"7","author":"S Van de Wall","year":"2018","unstructured":"Van de Wall S, Ljungberg K, Ip PP, Boerma A, Knudsen ML, Nijman HW et al (2018) Potent therapeutic efficacy of an alphavirus replicon DNA vaccine expressing human papilloma virus E6 and E7 antigens. Oncoimmunology 7:e1487913","journal-title":"Oncoimmunology"},{"key":"6_CR22","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1038\/sj.gt.3302864","volume":"14","author":"MC Leslie","year":"2007","unstructured":"Leslie MC, Zhao YJ, Lachman LB, Hwu P, Wu GJ, Bar-Eli M (2007) Immunization against MUC18\/MCAM, a novel antigen that drives melanoma invasion and metastasis. Gene Ther 14:316\u2013323","journal-title":"Gene Ther"},{"key":"6_CR23","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1016\/j.vaccine.2009.09.135","volume":"28","author":"DI Bernstein","year":"2010","unstructured":"Bernstein DI, Reap EA, Katen K, Watson A, Smith K, Norberg P et al (2010) Randomized, double-blind, Phase I trial on an alphavirus replicon vaccine for cytomegalovirus in CMV negative volunteers. Vaccine 28:484\u2013493","journal-title":"Vaccine"},{"key":"6_CR24","doi-asserted-by":"publisher","first-page":"1651","DOI":"10.1128\/CVI.00258-12","volume":"19","author":"M Wecker","year":"2012","unstructured":"Wecker M, Gilbert P, Russell N, Hural J, Allen M, Pensiero M et al (2012) Phase I safety and immunogenicity evaluations of an alphavirus replicon HIV-1 subtype C gag vaccine in healthy HIV-1-uninfected adults. Clin. Vaccine Immunol 19:1651\u20131660","journal-title":"Vaccine Immunol"},{"key":"6_CR25","doi-asserted-by":"publisher","first-page":"3234","DOI":"10.1172\/JCI42672","volume":"120","author":"MA Morse","year":"2010","unstructured":"Morse MA, Hobelka AC, Osada T, Berglund P, Hubby B, Negri S et al (2010) An alphavirus vector overcomes the presence of neutralizing antibodies and elevated numbers of Tregs to induce immune responses in humans with advanced cancer. J Clin Investig 120:3234\u20133241","journal-title":"J Clin Investig"},{"key":"6_CR26","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1016\/j.vaccine.2012.11.096","volume":"31","author":"SF Slovin","year":"2013","unstructured":"Slovin SF, Kehoe M, Durso R, Fernandez C, Olson W, Gao JP et al (2013) A phase I dose escalation trial of vaccine replicon particles (VRP) expressing prostate-specific membrane antigen (PSMA) in subjects with prostate cancer. Vaccine 31:943\u2013949","journal-title":"Vaccine"},{"key":"6_CR27","series-title":"Neuromethods","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4939-3064-7_7","volume-title":"Receptor and ion channel detection in the brain: methods and protocols","author":"MU Ehrengruber","year":"2016","unstructured":"Ehrengruber MU, Lundstrom K (2016) Recombinant alphavirus-mediated expression of ion channels and receptors in the brain. In: Luj\u00e1n R, Ciruela F (eds) Receptor and ion channel detection in the brain: methods and protocols, Neuromethods, vol 110. Springer Science + Business Media, New York, NY. https:\/\/doi.org\/10.1007\/978-1-4939-3064-7_7"},{"key":"6_CR28","doi-asserted-by":"publisher","first-page":"1700","DOI":"10.1016\/S0028-3908(99)00265-8","volume":"39","author":"C Schweitzer","year":"2000","unstructured":"Schweitzer C, Kratzeisen C, Adam G, Lundstrom K, Malherbe P, Ohresser S et al (2000) Characterization of [3H] LY-354740 binding of rat mGlu2 and mGlu3 receptors expressed in CHO cells using Semliki Forest virus vectors. Neuropharmacology 39:1700\u20131706","journal-title":"Neuropharmacology"},{"key":"6_CR29","first-page":"916","volume":"11","author":"P Berglund","year":"1993","unstructured":"Berglund P, Sj\u00f6berg M, Garoff H, Atkins GJ, Sheahan BJ, Liljestrom P (1993) Semliki Forest virus expression system: production of conditionally infectious recombinant particles. Bio\/Technology 11:916\u2013920","journal-title":"Bio\/Technology"},{"key":"6_CR30","doi-asserted-by":"publisher","first-page":"4107","DOI":"10.1128\/jvi.65.8.4107-4113.1991","volume":"65","author":"P Liljestrom","year":"1991","unstructured":"Liljestrom P, Lusa S, Huylebroeck D, Garoff H (1991) In vitro mutagenesis of a full-length cDNA clone of Semliki Forest virus: the small 6,000-molecular weight membrane protein modulates virus release. J Virol 65:4107\u20134113","journal-title":"J Virol"},{"key":"6_CR31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/13550280390173382","volume":"9","author":"MJ V\u00e4h\u00e4-Koskela","year":"2003","unstructured":"V\u00e4h\u00e4-Koskela MJ, Tuittila MT, Nygardas PT, Nyman JK, Ehrengruber MU, Renggli M (2003) A novel neurotropic expression vector based on the avirulent A7(74) strain of Semliki Forest virus. J Neurovirol 9:1\u201315","journal-title":"J Neurovirol"},{"key":"6_CR32","doi-asserted-by":"publisher","first-page":"18060","DOI":"10.1074\/jbc.273.29.18060","volume":"273","author":"DP DiCiommo","year":"1998","unstructured":"DiCiommo DP, Bremner R (1998) Rapid, high-level protein production using DNA-based Semliki Forest virus vectors. J Biol Chem 273:18060\u201318066","journal-title":"J Biol Chem"},{"key":"6_CR33","doi-asserted-by":"publisher","first-page":"3320","DOI":"10.1167\/iovs.04-0140","volume":"45","author":"DP DiCiommo","year":"2004","unstructured":"DiCiommo DP, Duckett A, Burcescu I, Bremner R, Gallie BR (2004) Retinoblastoma protein purification and transduction of retina and retinoblastoma cells using improved alphavirus vectors. Invest. Ophthalmol Vis Sci 45:3320\u20133329","journal-title":"Ophthalmol Vis Sci"},{"key":"6_CR34","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/j.jviromet.2007.10.007","volume":"148","author":"L Ulper","year":"2008","unstructured":"Ulper L, Sarand I, Rausalu K, Merits A (2008) Construction, properties, and potential application of infectious plasmids containing Semliki Forest virus full-length cDNA with a n inserted intron. J Virol Methods 148:265\u2013270","journal-title":"J Virol Methods"},{"key":"6_CR35","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1016\/j.jviromet.2013.07.058","volume":"193","author":"AL Puglia","year":"2013","unstructured":"Puglia AL, Rezende AG, Jorge SA, Wagner R, Pereira CA, Astray RM (2013) Quantitative RT-PCR for titration of replication-defective recombinant Semliki Forest virus. J Virol Methods 193:647\u2013652","journal-title":"J Virol Methods"},{"key":"6_CR36","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.jviromet.2012.09.026","volume":"187","author":"D Juare","year":"2013","unstructured":"Juare D, Long KC, Aguilar P, Kochel TJ, Halsey JS (2013) Assessment of plaque assay methods for alphaviruses. J Virol Methods 187:185\u2013189","journal-title":"J Virol Methods"},{"key":"6_CR37","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0012670","volume":"5","author":"F Avogadri","year":"2010","unstructured":"Avogadri F, Merghoub T, Maughan MF, Hirschhorn-Cymerman D, Morris J, Ritter E et al (2010) Alphavirus replicon particles expressing TRP-2 provide potent therapeutic effect on melanoma through activation of humoral and cellular immunity. PLoS One 5:e12670","journal-title":"PLoS One"},{"key":"6_CR38","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1038\/nm813","volume":"5","author":"WW Leitner","year":"2003","unstructured":"Leitner WW, Hwang NL, de Veer MJ, Zhou A et al (2003) Alphavirus-based DNA vaccine breaks immunological tolerance by activating innate antiviral pathways. Nat Med 5:33\u201339","journal-title":"Nat Med"},{"key":"6_CR39","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1006\/viro.1998.9357","volume":"250","author":"G Colombage","year":"1998","unstructured":"Colombage G, Hall R, Pavy M, Lobigs M (1998) DNA-based and alphavirus-vectored immunization with PrM and E proteins elicits long-lived and protective immunity against the flavivirus, Murray Valley encephalitis virus. Virology 250:151\u2013163","journal-title":"Virology"},{"key":"6_CR40","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1016\/S1525-0016(02)00056-4","volume":"7","author":"K Lundstrom","year":"2003","unstructured":"Lundstrom K, Abenavoli A, Malgaroli A, Ehrengruber MU (2003) Novel Semliki Forest virus vectors with reduced toxicity and temperature-sensitivity for long-term enhancement of transgene expression. Mol Ther 7:202\u2013209","journal-title":"Mol Ther"},{"key":"6_CR41","doi-asserted-by":"publisher","first-page":"12989","DOI":"10.1073\/pnas.95.22.12989","volume":"95","author":"EV Agapov","year":"1998","unstructured":"Agapov EV, Frolov I, Lindenbach BD, Pragal PM, Schlesinger S, Rice CM (1998) Noncythopathic Sindbis virus RNA vectors for heterologous gene expression. Proc Natl Acad Sci U S A 95:12989\u201312994","journal-title":"Proc Natl Acad Sci U S A"},{"key":"6_CR42","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1038\/nbt1194-1127","volume":"12","author":"EM Sj\u00f6berg","year":"1994","unstructured":"Sj\u00f6berg EM, Suomalainen M, Garoff H (1994) A significantly improved Semliki Forest virus expression system based on translation enhancer segments from the viral capsid gene. Bio\/Technology 12:1127\u20131131","journal-title":"Bio\/Technology"},{"key":"6_CR43","doi-asserted-by":"publisher","first-page":"14604","DOI":"10.1073\/pnas.1209367109","volume":"109","author":"AJ Geall","year":"2012","unstructured":"Geall AJ, Verma A, Otten GR, Shaw CA, Hekele A, Banerjee K et al (2012) Nonviral delivery of self-amplifying RNA vaccines. Proc Natl Acad Sci U S A 109:14604\u201314609","journal-title":"Proc Natl Acad Sci U S A"},{"key":"6_CR44","first-page":"3A","volume":"3","author":"D Voytas","year":"2001","unstructured":"Voytas D, Ke N (2001) Detection and quantitation of radiolabeled proteins and DNA in gels and blot. Curr Protoc Mol Biol Appendix 3:3A","journal-title":"Curr Protoc Mol Biol Appendix"}],"container-title":["Methods in Molecular Biology","Vaccine Delivery Technology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-1-0716-0795-4_6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,26]],"date-time":"2023-01-26T18:04:23Z","timestamp":1674756263000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/978-1-0716-0795-4_6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,22]]},"ISBN":["9781071607947","9781071607954"],"references-count":44,"URL":"https:\/\/doi.org\/10.1007\/978-1-0716-0795-4_6","relation":{},"ISSN":["1064-3745","1940-6029"],"issn-type":[{"type":"print","value":"1064-3745"},{"type":"electronic","value":"1940-6029"}],"subject":[],"published":{"date-parts":[[2020,9,22]]},"assertion":[{"value":"22 September 2020","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}